PET Drugs Draft Rule Relaxes Proposed GMP Requirements After Comments
Executive Summary
FDA's latest proposed rule on current good manufacturing practices for positron emission tomography products drops several requirements that had been included in previous iterations of the reg
You may also be interested in...
Good Manufacturing Practices: FDA’s 21st Century Quality Initiative Turns From Concept To Implementation
The pharmaceutical industry is welcoming FDA's move toward greater flexibility in quality control inspections and manufacturing changes for firms with good quality systems but seeks more concrete information on how flexibility will be achieved in practice
PET Drug Manufacturers Must Establish Quality Control Units - GMP Draft Reg
PET manufacturers must establish quality control units to oversee production operations, FDA's "Preliminary Draft Regulation on Current Good Manufacturing Practices for PET Drugs" states.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011